Vancouver Prostate Centre Archives

ADT and Radiation

Posted by Mira Keyes, MD, FRCPC, FABS | Jun 2025

Mira Keyes, MD, FRCPC, FABS, discusses the role of androgen deprivation therapy (ADT) combined with radiation for prostate cancer treatment.

Use of Biomarkers in NMIBC: What’s New and What Should We Use?

Posted by Peter Black, MD, FACS, FRCSC | Dec 2022

Dr. Peter C. Black moderated an insightful panel discussion exploring the latest advancements in the use of biomarkers for non-muscle invasive bladder cancer (NMIBC) and their potential integration into clinical practice.

More Arrows in Our Quiver – Targeting the Adaptive Molecular Landscape of Advanced Prostate Cancer

Posted by Martin Gleave, MD, FRCSC, FACS | Feb 2020

Martin Gleave, MD, FRCSC, FACS, Co-Founder and Director of the Vancouver Prostate Centre, reviews the molecular mechanisms of treatment resistance in metastatic castrate-resistant prostate cancer, as well as efforts to refine precision treatment of disease. He discusses how defining these mechanisms has yielded new processes and drugs, shows how molecular subclassification is key to drug selection and sequencing, and highlights new studies demonstrating how circulating tumor DNA monitoring can show real-time genetic adaptations in cancer cells.

Multimodal Approach to Advanced Prostate Cancer

Posted by Martin Gleave, MD, FRCSC, FACS | May 2018

Martin E. Gleave, MD, FRCSC, FACS, discusses his views on improving advanced prostate cancer treatment approaches. Specifically, he emphasizes methods that integrate various treatment options beyond surgical castration and androgen deprivation therapy (ADT).